Processes for the preparation of n-(1-methylcyclopropyl)-2-(3-pyridinyl)-2h-indazole-4-carboxamide and intermediates thereof
US-2025179043-A1 · Jun 5, 2025 · US
He Linli is listed as an inventor on 4 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | He Linli |
| Total patents | 4 |
| First publication | Jan 4, 2018 |
| Latest publication | Jun 5, 2025 |
Publications ranked by popularity score, then publication date.
US-2025179043-A1 · Jun 5, 2025 · US
US-2025163010-A1 · May 22, 2025 · US
US-10100060-B2 · Oct 16, 2018 · US
US-2018002341-A1 · Jan 4, 2018 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Fmc Corp | 2 |
| Teva Pharmaceuticals Int Gmbh | 1 |
| Xenon Pharmaceuticals Inc | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| B01J31/0244 | 4 |
| B01J31/0232 | 2 |
| B01J2231/40 | 2 |
| B01J31/0204 | 2 |
| B01J31/0271 | 2 |